| UniProt ID | MCM5_HUMAN | |
|---|---|---|
| UniProt AC | P33992 | |
| Protein Name | DNA replication licensing factor MCM5 | |
| Gene Name | MCM5 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 734 | |
| Subcellular Localization | Nucleus . Cytoplasm, cytosol . | |
| Protein Description | Acts as component of the MCM2-7 complex (MCM complex) which is the putative replicative helicase essential for 'once per cell cycle' DNA replication initiation and elongation in eukaryotic cells. The active ATPase sites in the MCM2-7 ring are formed through the interaction surfaces of two neighboring subunits such that a critical structure of a conserved arginine finger motif is provided in trans relative to the ATP-binding site of the Walker A box of the adjacent subunit. The six ATPase active sites, however, are likely to contribute differentially to the complex helicase activity (By similarity). Interacts with MCMBP.. | |
| Protein Sequence | MSGFDDPGIFYSDSFGGDAQADEGQARKSQLQRRFKEFLRQYRVGTDRTGFTFKYRDELKRHYNLGEYWIEVEMEDLASFDEDLADYLYKQPAEHLQLLEEAAKEVADEVTRPRPSGEEVLQDIQVMLKSDASPSSIRSLKSDMMSHLVKIPGIIIAASAVRAKATRISIQCRSCRNTLTNIAMRPGLEGYALPRKCNTDQAGRPKCPLDPYFIMPDKCKCVDFQTLKLQELPDAVPHGEMPRHMQLYCDRYLCDKVVPGNRVTIMGIYSIKKFGLTTSRGRDRVGVGIRSSYIRVLGIQVDTDGSGRSFAGAVSPQEEEEFRRLAALPNVYEVISKSIAPSIFGGTDMKKAIACLLFGGSRKRLPDGLTRRGDINLLMLGDPGTAKSQLLKFVEKCSPIGVYTSGKGSSAAGLTASVMRDPSSRNFIMEGGAMVLADGGVVCIDEFDKMREDDRVAIHEAMEQQTISIAKAGITTTLNSRCSVLAAANSVFGRWDETKGEDNIDFMPTILSRFDMIFIVKDEHNEERDVMLAKHVITLHVSALTQTQAVEGEIDLAKLKKFIAYCRVKCGPRLSAEAAEKLKNRYIIMRSGARQHERDSDRRSSIPITVRQLEAIVRIAEALSKMKLQPFATEADVEEALRLFQVSTLDAALSGTLSGVEGFTSQEDQEMLSRIEKQLKRRFAIGSQVSEHSIIKDFTKQKYPEHAIHKVLQLMLRRGEIQHRMQRKVLYRLK | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MSGFDDPGI ------CCCCCCCCC | 48.44 | 18491316 | |
| 2 | Phosphorylation | ------MSGFDDPGI ------CCCCCCCCC | 48.44 | 26552605 | |
| 11 | Phosphorylation | FDDPGIFYSDSFGGD CCCCCCCCCCCCCCC | 15.06 | 28450419 | |
| 12 | Phosphorylation | DDPGIFYSDSFGGDA CCCCCCCCCCCCCCC | 18.94 | 28450419 | |
| 14 | Phosphorylation | PGIFYSDSFGGDAQA CCCCCCCCCCCCCCC | 21.61 | 28450419 | |
| 36 | Ubiquitination | SQLQRRFKEFLRQYR HHHHHHHHHHHHHHC | 45.83 | - | |
| 54 | Ubiquitination | DRTGFTFKYRDELKR CCCCCEEEEHHHHHH | 36.00 | - | |
| 55 | Phosphorylation | RTGFTFKYRDELKRH CCCCEEEEHHHHHHH | 21.07 | 28152594 | |
| 60 | Acetylation | FKYRDELKRHYNLGE EEEHHHHHHHCCCCC | 34.77 | 25953088 | |
| 129 | Ubiquitination | QDIQVMLKSDASPSS HHHHHHHHCCCCHHH | 28.35 | - | |
| 130 | Phosphorylation | DIQVMLKSDASPSSI HHHHHHHCCCCHHHH | 34.15 | 20068231 | |
| 133 | Phosphorylation | VMLKSDASPSSIRSL HHHHCCCCHHHHHHH | 30.24 | 30576142 | |
| 135 | Phosphorylation | LKSDASPSSIRSLKS HHCCCCHHHHHHHHH | 35.58 | 25262027 | |
| 136 | Phosphorylation | KSDASPSSIRSLKSD HCCCCHHHHHHHHHH | 25.96 | 25262027 | |
| 139 | Phosphorylation | ASPSSIRSLKSDMMS CCHHHHHHHHHHHHH | 38.18 | 27251275 | |
| 141 | Acetylation | PSSIRSLKSDMMSHL HHHHHHHHHHHHHHH | 45.73 | 25953088 | |
| 141 | Ubiquitination | PSSIRSLKSDMMSHL HHHHHHHHHHHHHHH | 45.73 | 21890473 | |
| 142 | Phosphorylation | SSIRSLKSDMMSHLV HHHHHHHHHHHHHHH | 35.71 | 21406692 | |
| 146 | Phosphorylation | SLKSDMMSHLVKIPG HHHHHHHHHHHCCCH | 13.66 | 21406692 | |
| 150 | Ubiquitination | DMMSHLVKIPGIIIA HHHHHHHCCCHHHEE | 49.93 | - | |
| 159 | Phosphorylation | PGIIIAASAVRAKAT CHHHEEHHHHHHHCC | 20.48 | 20068231 | |
| 178 | Phosphorylation | QCRSCRNTLTNIAMR EEHHHCCHHHHHHHC | 18.66 | 27080861 | |
| 184 | Sulfoxidation | NTLTNIAMRPGLEGY CHHHHHHHCCCCCCC | 4.74 | 21406390 | |
| 206 | Ubiquitination | TDQAGRPKCPLDPYF CCCCCCCCCCCCCCE | 47.31 | - | |
| 212 | Phosphorylation | PKCPLDPYFIMPDKC CCCCCCCCEECCCCC | 12.85 | - | |
| 218 | Ubiquitination | PYFIMPDKCKCVDFQ CCEECCCCCEEEECC | 29.71 | - | |
| 220 | Acetylation | FIMPDKCKCVDFQTL EECCCCCEEEECCEE | 42.93 | 23749302 | |
| 220 | Ubiquitination | FIMPDKCKCVDFQTL EECCCCCEEEECCEE | 42.93 | - | |
| 228 | Acetylation | CVDFQTLKLQELPDA EEECCEEEHHHCCCC | 52.06 | 25953088 | |
| 228 | Ubiquitination | CVDFQTLKLQELPDA EEECCEEEHHHCCCC | 52.06 | - | |
| 241 | Sulfoxidation | DAVPHGEMPRHMQLY CCCCCCCCCHHHHHH | 4.12 | 21406390 | |
| 248 | Phosphorylation | MPRHMQLYCDRYLCD CCHHHHHHHHHHHCC | 3.87 | - | |
| 251 | Methylation | HMQLYCDRYLCDKVV HHHHHHHHHHCCCCC | 23.82 | 115482899 | |
| 256 | 2-Hydroxyisobutyrylation | CDRYLCDKVVPGNRV HHHHHCCCCCCCCCE | 44.10 | - | |
| 256 | Acetylation | CDRYLCDKVVPGNRV HHHHHCCCCCCCCCE | 44.10 | 25953088 | |
| 256 | Ubiquitination | CDRYLCDKVVPGNRV HHHHHCCCCCCCCCE | 44.10 | - | |
| 269 | Phosphorylation | RVTIMGIYSIKKFGL CEEEEEEEEEEECCC | 9.90 | - | |
| 270 | Phosphorylation | VTIMGIYSIKKFGLT EEEEEEEEEEECCCC | 26.47 | 24719451 | |
| 272 | Acetylation | IMGIYSIKKFGLTTS EEEEEEEEECCCCCC | 35.79 | 25953088 | |
| 273 | Acetylation | MGIYSIKKFGLTTSR EEEEEEEECCCCCCC | 42.89 | 25953088 | |
| 273 | Ubiquitination | MGIYSIKKFGLTTSR EEEEEEEECCCCCCC | 42.89 | - | |
| 277 | Phosphorylation | SIKKFGLTTSRGRDR EEEECCCCCCCCCCC | 24.09 | 28555341 | |
| 278 | Phosphorylation | IKKFGLTTSRGRDRV EEECCCCCCCCCCCC | 22.82 | 23186163 | |
| 279 | Phosphorylation | KKFGLTTSRGRDRVG EECCCCCCCCCCCCC | 27.74 | 23186163 | |
| 280 | Methylation | KFGLTTSRGRDRVGV ECCCCCCCCCCCCCC | 41.91 | 82797193 | |
| 303 | Phosphorylation | VLGIQVDTDGSGRSF EEEEEEECCCCCCCC | 43.32 | - | |
| 309 | Phosphorylation | DTDGSGRSFAGAVSP ECCCCCCCCCCCCCH | 23.99 | 23186163 | |
| 315 | Phosphorylation | RSFAGAVSPQEEEEF CCCCCCCCHHHHHHH | 21.97 | 23401153 | |
| 332 | Phosphorylation | LAALPNVYEVISKSI HHHCCCHHHHHHHHH | 15.89 | 28152594 | |
| 336 | Phosphorylation | PNVYEVISKSIAPSI CCHHHHHHHHHCHHH | 26.06 | 28152594 | |
| 337 | Ubiquitination | NVYEVISKSIAPSIF CHHHHHHHHHCHHHH | 34.45 | 21890473 | |
| 338 | Phosphorylation | VYEVISKSIAPSIFG HHHHHHHHHCHHHHC | 19.72 | 27362937 | |
| 342 | Phosphorylation | ISKSIAPSIFGGTDM HHHHHCHHHHCCCCH | 22.87 | 27362937 | |
| 350 | Succinylation | IFGGTDMKKAIACLL HHCCCCHHHHHHHHH | 41.69 | 23954790 | |
| 350 | Ubiquitination | IFGGTDMKKAIACLL HHCCCCHHHHHHHHH | 41.69 | - | |
| 351 | Acetylation | FGGTDMKKAIACLLF HCCCCHHHHHHHHHH | 38.09 | 26051181 | |
| 351 | Ubiquitination | FGGTDMKKAIACLLF HCCCCHHHHHHHHHH | 38.09 | - | |
| 361 | Phosphorylation | ACLLFGGSRKRLPDG HHHHHCCCCCCCCCC | 34.70 | 27362937 | |
| 363 | Ubiquitination | LLFGGSRKRLPDGLT HHHCCCCCCCCCCCC | 61.04 | - | |
| 379 | Sulfoxidation | RGDINLLMLGDPGTA CCCEEEEEECCCCCH | 4.41 | 21406390 | |
| 385 | Phosphorylation | LMLGDPGTAKSQLLK EEECCCCCHHHHHHH | 35.98 | - | |
| 387 | Acetylation | LGDPGTAKSQLLKFV ECCCCCHHHHHHHHH | 38.27 | 7833957 | |
| 387 | Ubiquitination | LGDPGTAKSQLLKFV ECCCCCHHHHHHHHH | 38.27 | - | |
| 392 | 2-Hydroxyisobutyrylation | TAKSQLLKFVEKCSP CHHHHHHHHHHHCCC | 56.83 | - | |
| 392 | Acetylation | TAKSQLLKFVEKCSP CHHHHHHHHHHHCCC | 56.83 | 19608861 | |
| 392 | Ubiquitination | TAKSQLLKFVEKCSP CHHHHHHHHHHHCCC | 56.83 | 19608861 | |
| 396 | 2-Hydroxyisobutyrylation | QLLKFVEKCSPIGVY HHHHHHHHCCCCEEE | 34.41 | - | |
| 396 | Acetylation | QLLKFVEKCSPIGVY HHHHHHHHCCCCEEE | 34.41 | 19608861 | |
| 396 | Malonylation | QLLKFVEKCSPIGVY HHHHHHHHCCCCEEE | 34.41 | 26320211 | |
| 396 | Ubiquitination | QLLKFVEKCSPIGVY HHHHHHHHCCCCEEE | 34.41 | 19608861 | |
| 403 | Phosphorylation | KCSPIGVYTSGKGSS HCCCCEEEECCCCCC | 7.03 | 28152594 | |
| 404 | Phosphorylation | CSPIGVYTSGKGSSA CCCCEEEECCCCCCC | 28.70 | 28152594 | |
| 405 | Phosphorylation | SPIGVYTSGKGSSAA CCCEEEECCCCCCCC | 22.33 | 28152594 | |
| 407 | Ubiquitination | IGVYTSGKGSSAAGL CEEEECCCCCCCCCC | 56.22 | - | |
| 409 | Phosphorylation | VYTSGKGSSAAGLTA EEECCCCCCCCCCCH | 21.93 | 21406692 | |
| 410 | Phosphorylation | YTSGKGSSAAGLTAS EECCCCCCCCCCCHH | 30.70 | 21406692 | |
| 415 | Phosphorylation | GSSAAGLTASVMRDP CCCCCCCCHHHCCCH | 18.90 | 21406692 | |
| 417 | Phosphorylation | SAAGLTASVMRDPSS CCCCCCHHHCCCHHH | 15.94 | 21406692 | |
| 419 | Sulfoxidation | AGLTASVMRDPSSRN CCCCHHHCCCHHHCC | 3.59 | 21406390 | |
| 423 | Phosphorylation | ASVMRDPSSRNFIME HHHCCCHHHCCEEEE | 46.34 | - | |
| 424 | Phosphorylation | SVMRDPSSRNFIMEG HHCCCHHHCCEEEEC | 36.31 | - | |
| 471 | Ubiquitination | QQTISIAKAGITTTL HHCCEEECCCCCCCC | 45.54 | 21890473 | |
| 482 | S-nitrosocysteine | TTTLNSRCSVLAAAN CCCCHHHHHHHHHHH | 3.11 | - | |
| 482 | S-nitrosylation | TTTLNSRCSVLAAAN CCCCHHHHHHHHHHH | 3.11 | 19483679 | |
| 483 | Phosphorylation | TTLNSRCSVLAAANS CCCHHHHHHHHHHHH | 21.03 | 27080861 | |
| 498 | Phosphorylation | VFGRWDETKGEDNID HHCCCCCCCCCCCCC | 41.71 | 28851738 | |
| 499 | Ubiquitination | FGRWDETKGEDNIDF HCCCCCCCCCCCCCC | 59.25 | 21890473 | |
| 509 | Phosphorylation | DNIDFMPTILSRFDM CCCCCHHHHHHHCCE | 23.82 | 28851738 | |
| 512 | Phosphorylation | DFMPTILSRFDMIFI CCHHHHHHHCCEEEE | 27.35 | 28851738 | |
| 528 | Methylation | KDEHNEERDVMLAKH ECCCCCHHHHHHHHH | 35.33 | 115482891 | |
| 531 | Sulfoxidation | HNEERDVMLAKHVIT CCCHHHHHHHHHHHE | 3.36 | 21406390 | |
| 561 | Acetylation | IDLAKLKKFIAYCRV CCHHHHHHHHHHHHC | 53.06 | 25953088 | |
| 561 | Ubiquitination | IDLAKLKKFIAYCRV CCHHHHHHHHHHHHC | 53.06 | - | |
| 565 | Phosphorylation | KLKKFIAYCRVKCGP HHHHHHHHHHCCCCC | 3.96 | 25367160 | |
| 581 | Acetylation | LSAEAAEKLKNRYII CCHHHHHHHHHCEEE | 61.10 | 23749302 | |
| 581 | Ubiquitination | LSAEAAEKLKNRYII CCHHHHHHHHHCEEE | 61.10 | - | |
| 583 | Ubiquitination | AEAAEKLKNRYIIMR HHHHHHHHHCEEEEC | 50.91 | - | |
| 586 | Phosphorylation | AEKLKNRYIIMRSGA HHHHHHCEEEECCCC | 12.28 | 20049867 | |
| 604 | Phosphorylation | ERDSDRRSSIPITVR CCCCCCCCCCCCHHH | 33.25 | 28450419 | |
| 605 | Phosphorylation | RDSDRRSSIPITVRQ CCCCCCCCCCCHHHH | 30.49 | 28450419 | |
| 609 | Phosphorylation | RRSSIPITVRQLEAI CCCCCCCHHHHHHHH | 12.32 | 23186163 | |
| 625 | Ubiquitination | RIAEALSKMKLQPFA HHHHHHHCCCCCCCC | 40.69 | - | |
| 627 | 2-Hydroxyisobutyrylation | AEALSKMKLQPFATE HHHHHCCCCCCCCCC | 47.94 | - | |
| 627 | Ubiquitination | AEALSKMKLQPFATE HHHHHCCCCCCCCCC | 47.94 | 21890473 | |
| 633 | Phosphorylation | MKLQPFATEADVEEA CCCCCCCCCCCHHHH | 31.89 | - | |
| 690 | Phosphorylation | FAIGSQVSEHSIIKD HCCCCCCCCHHHHHH | 23.19 | 23186163 | |
| 693 | Phosphorylation | GSQVSEHSIIKDFTK CCCCCCHHHHHHHHC | 23.20 | 23186163 | |
| 696 | Acetylation | VSEHSIIKDFTKQKY CCCHHHHHHHHCCCC | 45.15 | 19608861 | |
| 696 | Ubiquitination | VSEHSIIKDFTKQKY CCCHHHHHHHHCCCC | 45.15 | 21906983 | |
| 702 | Ubiquitination | IKDFTKQKYPEHAIH HHHHHCCCCCHHHHH | 65.41 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 633 | T | Phosphorylation | Kinase | CHEK1 | O14757 | GPS |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of MCM5_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of MCM5_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-392; LYS-396 AND LYS-696,AND MASS SPECTROMETRY. | |